Black Diamond Therapeutics, Inc. (BDTX) · INSIDERData sourcesSEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago
Public companyBlack Diamond Therapeutics, Inc.
BDTXCIK 0001701541
Price$1.86
1 year-53.3%
Disclosed transactions11
Buys / sells0 / 0
Max Insider Score17
Connections with evidence8
BDTX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 13 | | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | $13K 6,801 sh | Sep 18, 2026 | Sep 21, 2026 |
| 9 | | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 40.0K sh | Jun 26, 2026 | Jun 29, 2026 traded Jun 26, 2026 | +3d | SEC Form 4 | |
| 9 | KSKulkarni SamarthDirector | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 40.0K sh | Jun 26, 2026 | Jun 29, 2026 traded Jun 26, 2026 | +3d | SEC Form 4 | |
| 9 | CSCampbell ShannonDirector | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 40.0K sh | Jun 26, 2026 | Jun 29, 2026 traded Jun 26, 2026 | +3d | SEC Form 4 | |
| 17 | | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | $13K 7,907 sh | Jun 19, 2026 | Jun 22, 2026 traded Jun 19, 2026 | +3d | SEC Form 4 | |
| 13 | | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | $13K 6,105 sh | Mar 20, 2026 | Mar 20, 2026 traded Mar 20, 2026 | +0d | SEC Form 4 | |
| 9 | BEBuck ElizabethCHIEF SCIENTIFIC OFFICER | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 250.0K sh | Jan 21, 2026 | Jan 23, 2026 traded Jan 21, 2026 | +2d | SEC Form 4 | |
| 9 | VAVelleca Mark A.Director, PRESIDENT & CEO | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 600.0K sh | Jan 21, 2026 | Jan 23, 2026 traded Jan 21, 2026 | +2d | SEC Form 4 | |
| 9 | YSYurasov SergeyCHIEF MEDICAL OFFICER | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 250.0K sh | Jan 21, 2026 | Jan 23, 2026 traded Jan 21, 2026 | +2d | SEC Form 4 | |
| 9 | | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | — 200.0K sh | Jan 21, 2026 | Jan 23, 2026 traded Jan 21, 2026 | +2d | SEC Form 4 | |
| 13 | | BDTXBlack Diamond Therapeutics, Inc. Grant or award | A | $13K 4,665 sh | Dec 12, 2025 | Dec 15, 2025 traded Dec 12, 2025 | +3d | SEC Form 4 | |
SEE REMARKS · Jan 23, 2026